Genes, physical fitness and ageing

Ageing Research Reviews

Volumn 12, Issue 1, 2013, Pages 90-102

  Garatachea, Nuria ^a,b   Lucia, Alejandro ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

Ageing; Genes; Genetic variation; Physical fitness

Indexed keywords

ADENOSINE MONOPHOSPHATE DEAMINASE; ALPHA ACTININ 3; ANDROGEN RECEPTOR; ANGIOTENSINOGEN; APOLIPOPROTEIN E; BETA ADRENERGIC RECEPTOR; COLLAGEN TYPE 1; DIPEPTIDYL CARBOXYPEPTIDASE; FOLLISTATIN; INTERLEUKIN 6; MITOCHONDRIAL DNA; MYOSTATIN; NITRIC OXIDE SYNTHASE; UNCOUPLING PROTEIN; VITAMIN D RECEPTOR;

AEROBIC CAPACITY; AGING; CARDIOVASCULAR SYSTEM; CHRONIC DISEASE; DISABILITY; ELDERLY CARE; FITNESS; GAIT; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HEART OUTPUT; HERITABILITY; HUMAN; LIFESTYLE; MUSCLE FUNCTION; MUSCLE GROWTH; OXYGEN CONSUMPTION; PHENOTYPE; QUALITY OF LIFE; REVIEW; SATELLITE CELL; SELF CARE; SINGLE NUCLEOTIDE POLYMORPHISM; SKELETAL MUSCLE;

AGED; AGED, 80 AND OVER; AGING; ANAEROBIC THRESHOLD; FRAIL ELDERLY; GENES; GENETIC LINKAGE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MUSCLE, SKELETAL; PHYSICAL FITNESS; POLYMORPHISM, GENETIC;

EID: 84867379815     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2012.09.003     Document Type: Review

References (190)

1. Abellan van Kan G. Epidemiology and consequences of sarcopenia. J. Nutr. Health Aging 2009, 13:708-712.
2. Abney M., McPeek M.S., Ober C. Broad and narrow heritabilities of quantitative traits in a founder population. Am. J. Hum. Genet. 2001, 68:1302-1307.
3. Albert S.M., Gurland B., Maestre G., Jacobs D.M., Stern Y., Mayeux R. APOE genotype influences functional status among elderly without dementia. Am. J. Med. Genet. 1995, 60:583-587.
4. Alfred T., Ben-Shlomo Y., Cooper R., Hardy R., Cooper C., Deary I.J., Elliott J., Gunnell D., Harris S.E., Kivimaki M., Kumari M., Martin R.M., Power C., Sayer A.A., Starr J.M., Kuh D., Day I.N. Absence of association of a single-nucleotide polymorphism in the TERT-CLPTM1L locus with age-related phenotypes in a large multicohort study: the HALCyon programme. Aging Cell 2011, 10:520-532.
5. Alfred T., Ben-Shlomo Y., Cooper R., Hardy R., Cooper C., Deary I.J., Gaunt T.R., Gunnell D., Harris S.E., Kumari M., Martin R.M., Sayer A.A., Starr J.M., Kuh D., Day I.N. A multi-cohort study of polymorphisms in the GH/IGF axis and physical capability: the HALCyon programme. PLoS One 2012, 7:e29883.
6. Arden N.K., Spector T.D. Genetic influences on muscle strength, lean body mass, and bone mineral density: a twin study. J. Bone Miner. Res. 1997, 12:2076-2081.
7. Arking D.E., Fallin D.M., Fried L.P., Li T., Beamer B.A., Xue Q.L., Chakravarti A., Walston J. Variation in the ciliary neurotrophic factor gene and muscle strength in older Caucasian women. J. Am. Geriatr. Soc. 2006, 54:823-826.
8. Attia J., Ioannidis J.P., Thakkinstian A., McEvoy M., Scott R.J., Minelli C., Thompson J., Infante-Rivard C., Guyatt G. How to use an article about genetic association: B: Are the results of the study valid?. JAMA 2009, 301:191-197.
9. Bader G., Zuliani G., Kostner G.M., Fellin R. Apolipoprotein E polymorphism is not associated with longevity or disability in a sample of Italian octo- and nonagenarians. Gerontology 1998, 44:293-299.
10. Bahat G., Saka B., Erten N., Ozbek U., Coskunpinar E., Yildiz S., Sahinkaya T., Karan M.A. BsmI polymorphism in the vitamin D receptor gene is associated with leg extensor muscle strength in elderly men. Aging Clin. Exp. Res. 2010, 22:198-205.
11. Barr R., Macdonald H., Stewart A., McGuigan F., Rogers A., Eastell R., Felsenberg D., Gluer C., Roux C., Reid D.M. Association between vitamin D receptor gene polymorphisms, falls, balance and muscle power: results from two independent studies (APOSS and OPUS). Osteoporos Int. 2010, 21:457-466.
12. Baumgartner R.N., Koehler K.M., Gallagher D., Romero L., Heymsfield S.B., Ross R.R., Garry P.J., Lindeman R.D. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 1998, 147:755-763.
13. Bennermo M., Held C., Stemme S., Ericsson C.G., Silveira A., Green F., Tornvall P. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases?. Clin. Chem. 2004, 50:2136-2140.
14. Berk B.C., Vekshtein V., Gordon H.M., Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989, 13:305-314.
15. Bhasin S., Storer T.W. Anabolic applications of androgens for functional limitations associated with aging and chronic illness. Front. Horm. Res. 2009, 37:163-182.
16. Blazer D.G., Fillenbaum G., Burchett B. The APOE-E4 allele and the risk of functional decline in a community sample of African American and white older adults. J. Gerontol. A Biol. Sci. Med. Sci. 2001, 56:M785-M789.
17. Bouchard C., Daw E.W., Rice T., Perusse L., Gagnon J., Province M.A., Leon A.S., Rao D.C., Skinner J.S., Wilmore J.H. Familial resemblance for VO2 max in the sedentary state: the HERITAGE family study. Med. Sci. Sports Exerc. 1998, 30:252-258.
18. Buchman A.S., Boyle P.A., Wilson R.S., Beck T.L., Kelly J.F., Bennett D.A. Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons. Alzheimer Dis. Assoc. Disord. 2009, 23:63-69.
19. Bustamante-Ara N., Santiago C., Verde Z., Yvert T., Gomez-Gallego F., Rodriguez-Romo G., Gonzalez-Gil P., Serra-Rexach J.A., Ruiz J.R., Lucia A. ACE and ACTN3 genes and muscle phenotypes in nonagenarians. Int. J. Sports Med. 2010, 31:221-224.
20. Cannon B., Shabalina I.G., Kramarova T.V., Petrovic N., Nedergaard J. Uncoupling proteins: a role in protection against reactive oxygen species-or not?. Biochim. Biophys. Acta 2006, 1757:449-458.
21. Carmelli D., DeCarli C., Swan G.E., Kelly-Hayes M., Wolf P.A., Reed T., Guralnik J.M. The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function. J. Gerontol. A Biol. Sci. Med. Sci. 2000, 55:M103-M109.
22. Carmelli D., Reed T. Stability and change in genetic and environmental influences on hand-grip strength in older male twins. J. Appl. Physiol. 2000, 89:1879-1883.
23. Cesari M., Pahor M. Target population for clinical trials on sarcopenia. J. Nutr. Health Aging 2008, 12:470-478.
24. Charbonneau D.E., Hanson E.D., Ludlow A.T., Delmonico M.J., Hurley B.F., Roth S.M. ACE genotype and the muscle hypertrophic and strength responses to strength training. Med. Sci. Sports Exerc. 2008, 40:677-683.
25. Christensen K., Frederiksen H., Vaupel J.W., McGue M. Age trajectories of genetic variance in physical functioning: a longitudinal study of Danish twins aged 70 years and older. Behav. Genet. 2003, 33:125-136.
26. Christensen K., McGue M., Petersen I., Jeune B., Vaupel J.W. Exceptional longevity does not result in excessive levels of disability. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13274-13279.
27. Coggan A.R., Spina R.J., King D.S., Rogers M.A., Brown M., Nemeth P.M., Holloszy J.O. Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women. J. Gerontol. 1992, 47:B71-B76.
28. Conley K.E., Jubrias S.A., Esselman P.C. Oxidative capacity and ageing in human muscle. J. Physiol. 2000, 526(Pt 1):203-210.
29. Cooke J.P., Rossitch E., Andon N.A., Loscalzo J., Dzau V.J. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J. Clin. Invest. 1991, 88:1663-1671.
30. Corsi A.M., Ferrucci L., Gozzini A., Tanini A., Brandi M.L. Myostatin polymorphisms and age-related sarcopenia in the Italian population. J. Am. Geriatr. Soc. 2002, 50:1463.
31. Crocco P., Montesanto A., Passarino G., Rose G. A common polymorphism in the UCP3 promoter influences hand grip strength in elderly people. Biogerontology 2011, 12:265-271.
32. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., Boirie Y., Cederholm T., Landi F., Martin F.C., Michel J.P., Rolland Y., Schneider S.M., Topinkova E., Vandewoude M., Zamboni M. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39:412-423.
33. Danser A.H., Schalekamp M.A., Bax W.A., van den Brink A.M., Saxena P.R., Riegger G.A., Schunkert H. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995, 92:1387-1388.
34. Dato S., Montesanto A., Lagani V., Jeune B., Christensen K., Passarino G. Frailty phenotypes in the elderly based on cluster analysis: a longitudinal study of two Danish cohorts. Evidence for a genetic influence on frailty. Age 2012, 34:571-582.
35. Dawn Teare M., Barrett J.H. Genetic linkage studies. Lancet 2005, 366:1036-1044.
36. De Mars G., Windelinckx A., Beunen G., Delecluse C., Lefevre J., Thomis M.A. Polymorphisms in the CNTF and CNTF receptor genes are associated with muscle strength in men and women. J. Appl. Physiol. 2007, 102:1824-1831.
37. Deary I.J., Whalley L.J., Batty G.D., Starr J.M. Physical fitness and lifetime cognitive change. Neurology 2006, 67:1195-1200.
38. Degens H. Age-related changes in the microcirculation of skeletal muscle. Adv. Exp. Med. Biol. 1998, 454:343-348.
39. Delmonico M.J., Kostek M.C., Doldo N.A., Hand B.D., Walsh S., Conway J.M., Carignan C.R., Roth S.M., Hurley B.F. Alpha-actinin-3 (ACTN3) R577X polymorphism influences knee extensor peak power response to strength training in older men and women. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62:206-212.
40. Delmonico M.J., Zmuda J.M., Taylor B.C., Cauley J.A., Harris T.B., Manini T.M., Schwartz A., Li R., Roth S.M., Hurley B.F., Bauer D.C., Ferrell R.E., Newman A.B. Association of the ACTN3 genotype and physical functioning with age in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63:1227-1234.
41. Deng H.W., Lai D.B., Conway T., Li J., Xu F.H., Davies K.M., Recker R.R. Characterization of genetic and lifestyle factors for determining variation in body mass index, fat mass, percentage of fat mass, and lean mass. J. Clin. Densitom. 2001, 4:353-361.
42. Deschenes M.R. Effects of aging on muscle fibre type and size. Sports Med. 2004, 34:809-824.
43. Doherty T.J. Invited review: Aging and sarcopenia. J. Appl. Physiol. 2003, 95:1717-1727.
44. Echtay K.S. Mitochondrial uncoupling proteins--what is their physiological role?. Free Radic. Biol. Med. 2007, 43:1351-1371.
45. Eskurza I., Donato A.J., Moreau K.L., Seals D.R., Tanaka H. Changes in maximal aerobic capacity with age in endurance-trained women: 7-yr follow-up. J. Appl. Physiol. 2002, 92:2303-2308.
46. Etnier J.L., Caselli R.J., Reiman E.M., Alexander G.E., Sibley B.A., Tessier D., McLemore E.C. Cognitive performance in older women relative to ApoE-epsilon4 genotype and aerobic fitness. Med. Sci. Sports Exerc. 2007, 39:199-207.
47. Eynon N., Moran M., Birk R., Lucia A. The champions' mitochondria: is it genetically determined? A review on mitochondrial DNA and elite athletic performance. Physiol. Genom. 2011, 43:789-798.
48. Ferrell R.E., Conte V., Lawrence E.C., Roth S.M., Hagberg J.M., Hurley B.F. Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes. Genomics 1999, 62:203-207.
49. Fielding R.A., Vellas B., Evans W.J., Bhasin S., Morley J.E., Newman A.B., Abellan van Kan G., Andrieu S., Bauer J., Breuille D., Cederholm T., Chandler J., De Meynard C., Donini L., Harris T., Kannt A., Keime Guibert F., Onder G., Papanicolaou D., Rolland Y., Rooks D., Sieber C., Souhami E., Verlaan S., Zamboni M. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 2011, 12:249-256.
50. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998, 102:1369-1376.
51. Fleg J.L., Morrell C.H., Bos A.G., Brant L.J., Talbot L.A., Wright J.G., Lakatta E.G. Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation 2005, 112:674-682.
52. Folland J.P., Mc Cauley T.M., Phypers C., Hanson B., Mastana S.S. The relationship of testosterone and AR CAG repeat genotype with knee extensor muscle function of young and older men. Exp. Gerontol. 2012, 47:437-443.
53. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., Belmont J.W., Boudreau A., Hardenbol P., Leal S.M., Pasternak S., Wheeler D.A., Willis T.D., Yu F., Yang H., Zeng C., Gao Y., Hu H., Hu W., Li C., Lin W., Liu S., Pan H., Tang X., Wang J., Wang W., Yu J., Zhang B., Zhang Q., Zhao H., Zhou J., Gabriel S.B., Barry R., Blumenstiel B., Camargo A., Defelice M., Faggart M., Goyette M., Gupta S., Moore J., Nguyen H., Onofrio R.C., Parkin M., Roy J., Stahl E., Winchester E., Ziaugra L., Altshuler D., Shen Y., Yao Z., Huang W., Chu X., He Y., Jin L., Liu Y., Sun W., Wang H., Wang Y., Xiong X., Xu L., Waye M.M., Tsui S.K., Xue H., Wong J.T., Galver L.M., Fan J.B., Gunderson K., Murray S.S., Oliphant A.R., Chee M.S., Montpetit A., Chagnon F., Ferretti V., Leboeuf M., Olivier J.F., Phillips M.S., Roumy S., Sallee C., Verner A., Hudson T.J., Kwok P.Y., Cai D., Koboldt D.C., Miller R.D., Pawlikowska L., Taillon-Miller P., Xiao M., Tsui L.C., Mak W., Song Y.Q., Tam P.K., Nakamura Y., Kawaguchi T., Kitamoto T., Morizono T., Nagashima A., Ohnishi Y., Sekine A., Tanaka T., Tsunoda T., Deloukas P., Bird C.P., Delgado M., Dermitzakis E.T., Gwilliam R., Hunt S., Morrison J., Powell D., Stranger B.E., Whittaker P., Bentley D.R., Daly M.J., de Bakker P.I., Barrett J., Chretien Y.R., Maller J., McCarroll S., Patterson N., Pe'er I., Price A., Purcell S., Richter D.J., Sabeti P., Saxena R., Schaffner S.F., Sham P.C., Varilly P., Stein L.D., Krishnan L., Smith A.V., Tello-Ruiz M.K., Thorisson G.A., Chakravarti A., Chen P.E., Cutler D.J., Kashuk C.S., Lin S., Abecasis G.R., Guan W., Li Y., Munro H.M., Qin Z.S., Thomas D.J., McVean G., Auton A., Bottolo L., Cardin N., Eyheramendy S., Freeman C., Marchini J., Myers S., Spencer C., Stephens M., Donnelly P., Cardon L.R., Clarke G., Evans D.M., Morris A.P., Weir B.S., Mullikin J.C., Sherry S.T., Feolo M., Skol A., Zhang H., Matsuda I., Fukushima Y., Macer D.R., Suda E., Rotimi C.N., Adebamowo C.A., Ajayi I., Aniagwu T., Marshall P.A., Nkwodimmah C., Royal C.D., Leppert M.F., Dixon M., Peiffer A., Qiu R., Kent A., Kato K., Niikawa N., Adewole I.F., Knoppers B.M., Foster M.W., Clayton E.W., Watkin J., Muzny D., Nazareth L., Sodergren E., Weinstock G.M., Yakub I., Birren B.W., Wilson R.K., Fulton L.L., Rogers J., Burton J., Carter N.P., Clee C.M., Griffiths M., Jones M.C., McLay K., Plumb R.W., Ross M.T., Sims S.K., Willey D.L., Chen Z., Han H., Kang L., Godbout M., Wallenburg J.C., L'Archeveque P., Bellemare G., Saeki K., An D., Fu H., Li Q., Wang Z., Wang R., Holden A.L., Brooks L.D., McEwen J.E., Guyer M.S., Wang V.O., Peterson J.L., Shi M., Spiegel J., Sung L.M., Zacharia L.F., Collins F.S., Kennedy K., Jamieson R., Stewart J. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861.
54. Frederiksen H., Bathum L., Worm C., Christensen K., Puggaard L. ACE genotype and physical training effects: a randomized study among elderly Danes. Aging Clin. Exp. Res. 2003, 15:284-291.
55. Frederiksen H., Gaist D., Bathum L., Andersen K., McGue M., Vaupel J.W., Christensen K. Angiotensin I-converting enzyme (ACE) gene polymorphism in relation to physical performance, cognition and survival-a follow-up study of elderly Danish twins. Ann. Epidemiol. 2003, 13:57-65.
56. Frederiksen H., Gaist D., Petersen H.C., Hjelmborg J., McGue M., Vaupel J.W., Christensen K. Hand grip strength: a phenotype suitable for identifying genetic variants affecting mid- and late-life physical functioning. Genet. Epidemiol. 2002, 23:110-122.
57. Fried L.P., Ferrucci L., Darer J., Williamson J.D., Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59:255-263.
58. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., Seeman T., Tracy R., Kop W.J., Burke G., McBurnie M.A. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 2001, 56:M146-M156.
59. Frisoli A., Chaves P.H., Ingham S.J., Fried L.P. Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: Results from the Women's Health and Aging Study (WHAS) II. Bone 2011, 48:952-957.
60. Garatachea N., Fiuza-Luces C., Torres-Luque G., Yvert T., Santiago C., Gomez-Gallego F., Ruiz J.R., Lucia A. Single and combined influence of ACE and ACTN3 genotypes on muscle phenotypes in octogenarians. Eur. J. Appl. Physiol. 2012, 112:2409-2420.
61. Garber C.E., Blissmer B., Deschenes M.R., Franklin B.A., Lamonte M.J., Lee I.M., Nieman D.C., Swain D.P. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med. Sci. Sports Exerc. 2011, 43:1334-1359.
62. Geisterfer A.A., Peach M.J., Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 1988, 62:749-756.
63. Geusens P., Vandevyver C., Vanhoof J., Cassiman J.J., Boonen S., Raus J. Quadriceps and grip strength are related to vitamin D receptor genotype in elderly nonobese women. J. Bone Miner. Res. 1997, 12:2082-2088.
64. Giaccaglia V., Nicklas B., Kritchevsky S., Mychalecky J., Messier S., Bleecker E., Pahor M. Interaction between angiotensin converting enzyme insertion/deletion genotype and exercise training on knee extensor strength in older individuals. Int. J. Sports Med. 2008, 29:40-44.
65. Gonzalez-Freire M., Rodriguez-Romo G., Santiago C., Bustamante-Ara N., Yvert T., Gomez-Gallego F., Serra Rexach J.A., Ruiz J.R., Lucia A. The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan. Age (Dordr.) 2010, 32:405-409.
66. Gordon S.E., Davis B.S., Carlson C.J., Booth F.W. ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E150-E159.
67. Gross M. Clinical heterogeneity and molecular mechanisms in inborn muscle AMP deaminase deficiency. J. Inherit. Metab. Dis. 1997, 20:186-192.
68. Guillet C., Auguste P., Mayo W., Kreher P., Gascan H. Ciliary neurotrophic factor is a regulator of muscular strength in aging. J. Neurosci. 1999, 19:1257-1262.
69. Gustafson D.R., Mazzuco S., Ongaro F., Antuono P., Forloni G., Albani D., Gajo G.B., Durante E., Caberlotto L., Zanardo A., Siculi M., Gallucci M. Body mass index, cognition, disability, APOE genotype, and mortality: the " Treviso Longeva" Study. Am. J. Geriatr. Psychiatry 2012, 20:594-602.
70. Hagberg J.M., Allen W.K., Seals D.R., Hurley B.F., Ehsani A.A., Holloszy J.O. A hemodynamic comparison of young and older endurance athletes during exercise. J. Appl. Physiol. 1985, 58:2041-2046.
71. Hagberg J.M., McCole S.D., Brown M.D., Ferrell R.E., Wilund K.R., Huberty A., Douglass L.W., Moore G.E. ACE insertion/deletion polymorphism and submaximal exercise hemodynamics in postmenopausal women. J. Appl. Physiol. 2002, 92:1083-1088.
72. Hand B.D., Kostek M.C., Ferrell R.E., Delmonico M.J., Douglass L.W., Roth S.M., Hagberg J.M., Hurley B.F. Influence of promoter region variants of insulin-like growth factor pathway genes on the strength-training response of muscle phenotypes in older adults. J. Appl. Physiol. 2007, 103:1678-1687.
73. Hand B.D., McCole S.D., Brown M.D., Park J.J., Ferrell R.E., Huberty A., Douglass L.W., Hagberg J.M. NOS3 gene polymorphisms and exercise hemodynamics in postmenopausal women. Int. J. Sports Med. 2006, 27:951-958.
74. Hawkins S.A., Marcell T.J., Victoria Jaque S., Wiswell R.A. A longitudinal assessment of change in VO2max and maximal heart rate in master athletes. Med. Sci. Sports Exerc. 2001, 33:1744-1750.
75. Heuberger R.A. The frailty syndrome: a comprehensive review. J. Nutr. Gerontol. Geriatr. 2011, 30:315-368.
76. Ho Y.Y., Matteini A.M., Beamer B., Fried L., Xue Q.L., Arking D.E., Chakravarti A., Fallin M.D., Walston J. Exploring biologically relevant pathways in frailty. J. Gerontol. A Biol. Sci. Med. Sci. 2011, 66:975-979.
77. Hollenberg M., Yang J., Haight T.J., Tager I.B. Longitudinal changes in aerobic capacity: implications for concepts of aging. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61:851-858.
78. Hong E.P., Park J.W. Sample size and statistical power calculations. Genom. Inform. 2012, 10:117-122.
79. Hopkinson N.S., Li K.W., Kehoe A., Humphries S.E., Roughton M., Moxham J., Montgomery H., Polkey M.I. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am. J. Clin. Nutr. 2008, 87:385-390.
80. Hossack K.F., Bruce R.A. Maximal cardiac function in sedentary normal men and women: comparison of age-related changes. J. Appl. Physiol. 1982, 53:799-804.
81. Howard C., Ferrucci L., Sun K., Fried L.P., Walston J., Varadhan R., Guralnik J.M., Semba R.D. Oxidative protein damage is associated with poor grip strength among older women living in the community. J. Appl. Physiol. 2007, 103:17-20.
82. Hsu F.C., Lenchik L., Nicklas B.J., Lohman K., Register T.C., Mychaleckyj J., Langefeld C.D., Freedman B.I., Bowden D.W., Carr J.J. Heritability of body composition measured by DXA in the diabetes heart study. Obes. Res. 2005, 13:312-319.
83. Huygens W., Thomis M.A., Peeters M.W., Aerssens J., Janssen R., Vlietinck R.F., Beunen G. Linkage of myostatin pathway genes with knee strength in humans. Physiol. Genom. 2004, 17:264-270.
84. Huygens W., Thomis M.A., Peeters M.W., Vlietinck R.F., Beunen G.P. Determinants and upper-limit heritabilities of skeletal muscle mass and strength. Can. J. Appl. Physiol. 2004, 29:186-200.
85. International HapMap Consortium A haplotype map of the human genome. Nature 2005, 437:1299-1320.
86. Ishigai Y., Mori T., Ikeda T., Fukuzawa A., Shibano T. Role of bradykinin-NO pathway in prevention of cardiac hypertrophy by ACE inhibitor in rat cardiomyocytes. Am. J. Physiol. 1997, 273:H2659-H2663.
87. Ivey F.M., Roth S.M., Ferrell R.E., Tracy B.L., Lemmer J.T., Hurlbut D.E., Martel G.F., Siegel E.L., Fozard J.L., Jeffrey Metter E., Fleg J.L., Hurley B.F. Effects of age, gender, and myostatin genotype on the hypertrophic response to heavy resistance strength training. J. Gerontol. A Biol. Sci. Med. Sci. 2000, 55:M641-M648.
88. Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J. Am. Geriatr. Soc. 2006, 54:56-62.
89. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J. Am. Geriatr. Soc. 2002, 50:889-896.
90. Janssen I., Heymsfield S.B., Wang Z.M., Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J. Appl. Physiol. 2000, 89:81-88.
91. Janssen I., Shepard D.S., Katzmarzyk P.T., Roubenoff R. The healthcare costs of sarcopenia in the United States. J. Am. Geriatr. Soc. 2004, 52:80-85.
92. Kamel H.K. Sarcopenia and aging. Nutr. Rev. 2003, 61:157-167.
93. Karasik D., Zhou Y., Cupples L.A., Hannan M.T., Kiel D.P., Demissie S. Bivariate genome-wide linkage analysis of femoral bone traits and leg lean mass: Framingham study. J. Bone Miner. Res. 2009, 24:710-718.
94. Kenny A.M., McGee D., Joseph C., Covault J., Abreu C., Raisz L.G. Lack of association between androgen receptor polymorphisms and bone mineral density or physical function in older men. Endocr. Res. 2005, 31:285-293.
95. Kostek M.C., Devaney J.M., Gordish-Dressman H., Harris T.B., Thompson P.D., Clarkson P.M., Angelopoulos T.J., Gordon P.M., Moyna N.M., Pescatello L.S., Visich P.S., Zoeller R.F., Seip R.L., Garcia M., Li R., Zmuda J.M., Delmonico M.J., Kanaya A., Hoffman E.P. A polymorphism near IGF1 is associated with body composition and muscle function in women from the Health, Aging, and Body Composition Study. Eur. J. Appl. Physiol. 2010, 110:315-324.
96. Krivickas L.S., Walsh R., Amato A.A. Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO-029. Muscle Nerve 2009, 39:3-9.
97. Kulminski A., Ukraintseva S.V., Arbeev K.G., Manton K.G., Oshima J., Martin G.M., Yashin A.I. Association between APOE epsilon 2/epsilon 3/epsilon 4 polymorphism and disability severity in a national long-term care survey sample. Age Ageing 2008, 37:288-293.
98. Kumar V., Selby A., Rankin D., Patel R., Atherton P., Hildebrandt W., Williams J., Smith K., Seynnes O., Hiscock N., Rennie M.J. Age-related differences in the dose-response relationship of muscle protein synthesis to resistance exercise in young and old men. J. Physiol. 2009, 587:211-217.
99. Lakatta E.G., Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a set up for vascular disease. Circulation 2003, 107:139-146.
100. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., Funke R., Gage D., Harris K., Heaford A., Howland J., Kann L., Lehoczky J., LeVine R., McEwan P., McKernan K., Meldrim J., Mesirov J.P., Miranda C., Morris W., Naylor J., Raymond C., Rosetti M., Santos R., Sheridan A., Sougnez C., Stange-Thomann N., Stojanovic N., Subramanian A., Wyman D., Rogers J., Sulston J., Ainscough R., Beck S., Bentley D., Burton J., Clee C., Carter N., Coulson A., Deadman R., Deloukas P., Dunham A., Dunham I., Durbin R., French L., Grafham D., Gregory S., Hubbard T., Humphray S., Hunt A., Jones M., Lloyd C., McMurray A., Matthews L., Mercer S., Milne S., Mullikin J.C., Mungall A., Plumb R., Ross M., Shownkeen R., Sims S., Waterston R.H., Wilson R.K., Hillier L.W., McPherson J.D., Marra M.A., Mardis E.R., Fulton L.A., Chinwalla A.T., Pepin K.H., Gish W.R., Chissoe S.L., Wendl M.C., Delehaunty K.D., Miner T.L., Delehaunty A., Kramer J.B., Cook L.L., Fulton R.S., Johnson D.L., Minx P.J., Clifton S.W., Hawkins T., Branscomb E., Predki P., Richardson P., Wenning S., Slezak T., Doggett N., Cheng J.F., Olsen A., Lucas S., Elkin C., Uberbacher E., Frazier M., Gibbs R.A., Muzny D.M., Scherer S.E., Bouck J.B., Sodergren E.J., Worley K.C., Rives C.M., Gorrell J.H., Metzker M.L., Naylor S.L., Kucherlapati R.S., Nelson D.L., Weinstock G.M., Sakaki Y., Fujiyama A., Hattori M., Yada T., Toyoda A., Itoh T., Kawagoe C., Watanabe H., Totoki Y., Taylor T., Weissenbach J., Heilig R., Saurin W., Artiguenave F., Brottier P., Bruls T., Pelletier E., Robert C., Wincker P., Smith D.R., Doucette-Stamm L., Rubenfield M., Weinstock K., Lee H.M., Dubois J., Rosenthal A., Platzer M., Nyakatura G., Taudien S., Rump A., Yang H., Yu J., Wang J., Huang G., Gu J., Hood L., Rowen L., Madan A., Qin S., Davis R.W., Federspiel N.A., Abola A.P., Proctor M.J., Myers R.M., Schmutz J., Dickson M., Grimwood J., Cox D.R., Olson M.V., Kaul R., Shimizu N., Kawasaki K., Minoshima S., Evans G.A., Athanasiou M., Schultz R., Roe B.A., Chen F., Pan H., Ramser J., Lehrach H., Reinhardt R., McCombie W.R., de la Bastide M., Dedhia N., Blocker H., Hornischer K., Nordsiek G., Agarwala R., Aravind L., Bailey J.A., Bateman A., Batzoglou S., Birney E., Bork P., Brown D.G., Burge C.B., Cerutti L., Chen H.C., Church D., Clamp M., Copley R.R., Doerks T., Eddy S.R., Eichler E.E., Furey T.S., Galagan J., Gilbert J.G., Harmon C., Hayashizaki Y., Haussler D., Hermjakob H., Hokamp K., Jang W., Johnson L.S., Jones T.A., Kasif S., Kaspryzk A., Kennedy S., Kent W.J., Kitts P., Koonin E.V., Korf I., Kulp D., Lancet D., Lowe T.M., McLysaght A., Mikkelsen T., Moran J.V., Mulder N., Pollara V.J., Ponting C.P., Schuler G., Schultz J., Slater G., Smit A.F., Stupka E., Szustakowski J., Thierry-Mieg D., Thierry-Mieg J., Wagner L., Wallis J., Wheeler R., Williams A., Wolf Y.I., Wolfe K.H., Yang S.P., Yeh R.F., Collins F., Guyer M.S., Peterson J., Felsenfeld A., Wetterstrand K.A., Patrinos A., Morgan M.J., de Jong P., Catanese J.J., Osoegawa K., Shizuya H., Choi S., Chen Y.J. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
101. Landi F., Liperoti R., Fusco D., Mastropaolo S., Quattrociocchi D., Proia A., Tosato M., Bernabei R., Onder G. Sarcopenia and mortality among older nursing home residents. J. Am. Med. Directors Assoc. 2012, 13:121-126.
102. Lapauw B., Goemaere S., Crabbe P., Kaufman J.M., Ruige J.B. Is the effect of testosterone on body composition modulated by the androgen receptor gene CAG repeat polymorphism in elderly men?. Eur. J. Endocrinol. 2007, 156:395-401.
103. Lauretani F., Russo C.R., Bandinelli S., Bartali B., Cavazzini C., Di Iorio A., Corsi A.M., Rantanen T., Guralnik J.M., Ferrucci L. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J. Appl. Physiol. 2003, 95:1851-1860.
104. Lexell J., Taylor C.C., Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J. Neurol. Sci. 1988, 84:275-294.
105. Lima R.M., Leite T.K., Pereira R.W., Rabelo H.T., Roth S.M., Oliveira R.J. ACE and ACTN3 genotypes in older women: muscular phenotypes. Int. J. Sports Med. 2011, 32:66-72.
106. Little J., Higgins J.P., Ioannidis J.P., Moher D., Gagnon F., von Elm E., Khoury M.J., Cohen B., Davey-Smith G., Grimshaw J., Scheet P., Gwinn M., Williamson R.E., Zou G.Y., Hutchings K., Johnson C.Y., Tait V., Wiens M., Golding J., van Duijn C., McLaughlin J., Paterson A., Wells G., Fortier I., Freedman M., Zecevic M., King R., Infante-Rivard C., Stewart A., Birkett N. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum. Genet. 2009, 125:131-151.
107. Liu X.G., Tan L.J., Lei S.F., Liu Y.J., Shen H., Wang L., Yan H., Guo Y.F., Xiong D.H., Chen X.D., Pan F., Yang T.L., Zhang Y.P., Guo Y., Tang N.L., Zhu X.Z., Deng H.Y., Levy S., Recker R.R., Papasian C.J., Deng H.W. Genome-wide association and replication studies identified TRHR as an important gene for lean body mass. Am. J. Hum. Genet. 2009, 84:418-423.
108. MacArthur D.G., North K.N. A gene for speed? The evolution and function of alpha-actinin-3. Bioessays 2004, 26:786-795.
109. MacArthur D.G., North K.N. ACTN3: A genetic influence on muscle function and athletic performance. Exerc. Sport Sci. Rev. 2007, 35:30-34.
110. Manenschijn L., van den Akker E.L., Lamberts S.W., van Rossum E.F. Clinical features associated with glucocorticoid receptor polymorphisms. An overview. Ann. N. Y. Acad. Sci. 2009, 1179:179-198.
111. Masuki S., Mori M., Tabara Y., Miki T., Sakurai A., Morikawa M., Miyagawa K., Higuchi K., Nose H. Vasopressin V1a receptor polymorphism and interval walking training effects in middle-aged and older people. Hypertension 2010, 55:747-754.
112. McCauley T., Mastana S.S., Folland J.P. ACE I/D and ACTN3 R/X polymorphisms and muscle function and muscularity of older Caucasian men. Eur. J. Appl. Physiol. 2010, 109:269-277.
113. McCole S.D., Brown M.D., Moore G.E., Ferrell R.E., Wilund K.R., Huberty A., Douglass L.W., Hagberg J.M. Angiotensinogen M235 T polymorphism associates with exercise hemodynamics in postmenopausal women. Physiol. Genom. 2002, 10:63-69.
114. McCole S.D., Shuldiner A.R., Brown M.D., Moore G.E., Ferrell R.E., Wilund K.R., Huberty A., Douglass L.W., Hagberg J.M. Beta2- and beta3-adrenergic receptor polymorphisms and exercise hemodynamics in postmenopausal women. J. Appl. Physiol. 2004, 96:526-530.
115. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387:83-90.
116. Melzer D., Dik M.G., van Kamp G.J., Jonker C., Deeg D.J. The apolipoprotein E e4 polymorphism is strongly associated with poor mobility performance test results but not self-reported limitation in older people. J. Gerontol. A Biol. Sci. Med. Sci. 2005, 60:1319-1323.
117. Moore A.Z., Biggs M.L., Matteini A., O'Connor A., McGuire S., Beamer B.A., Fallin M.D., Fried L.P., Walston J., Chakravarti A., Arking D.E. Polymorphisms in the mitochondrial DNA control region and frailty in older adults. PLoS One 2010, 5:e11069.
118. Mora M., Perales M.J., Serra-Prat M., Palomera E., Buquet X., Oriola J., Puig-Domingo M. Aging phenotype and its relationship with IGF-I gene promoter polymorphisms in elderly people living in Catalonia. Growth Horm. IGF Res. 2011, 21:174-180.
119. Mora M., Sanchez L., Serra-Prat M., Palomera E., Blanco J., Aranda G., Falcon I., Cadenas I., Boquet X., Oriola J., Puig-Domingo M. Hormonal determinants and effect of ER22/23EK glucocorticoid receptor gene polymorphism on health status deterioration in the participants of the Mataro Ageing Study. Age 2012, 34:553-561.
120. Moreno Lima R., Silva de Abreu B., Gentil P., Cesar de Lima Lins T., Grattapaglia D., Pereira R.W., Jaco de Oliveira R. Lack of association between vitamin D receptor genotypes and haplotypes with fat-free mass in postmenopausal Brazilian women. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62:966-972.
121. Murakami S., Otsuki T., Maeda M., Miura Y., Morii S., Kiyokane K., Hayakawa S., Maeda A., Imakawa T., Harada S., Handa T., Nishimura Y., Kumagai N., Hayashi H., Chen Y., Suemori S., Fukushima Y., Nishida S., Fukushima K. Effects of vitamin D receptor gene polymorphisms on low-resistance training using exercise machines: the 'Power Rehabilitation' program. Int. J. Mol. Med. 2009, 23:81-88.
122. North K.N., Yang N., Wattanasirichaigoon D., Mills M., Easteal S., Beggs A.H. A common nonsense mutation results in alpha-actinin-3 deficiency in the general population. Nat. Genet. 1999, 21:353-354.
123. O'Dell S.D., Day I.N. Insulin-like growth factor II (IGF-II). Int. J. Biochem. Cell Biol. 1998, 30:767-771.
124. Ogawa T., Spina R.J., Martin W.H., Kohrt W.M., Schechtman K.B., Holloszy J.O., Ehsani A.A. Effects of aging, sex, and physical training on cardiovascular responses to exercise. Circulation 1992, 86:494-503.
125. Okamoto N., Nakatani T., Okamoto Y., Iwamoto J., Saeki K., Kurumatani N. Increasing the number of steps walked each day improves physical fitness in Japanese community-dwelling adults. Int. J. Sports Med. 2010, 31:277-282.
126. Onder G., Capoluongo E., Danese P., Settanni S., Russo A., Concolino P., Bernabei R., Landi F. Vitamin D receptor polymorphisms and falls among older adults living in the community: results from the ilSIRENTE study. J. Bone Miner. Res. 2008, 23:1031-1036.
127. Peeters G.M., van Schoor N.M., van Rossum E.F., Visser M., Lips P. The relationship between cortisol muscle mass and muscle strength in older persons and the role of genetic variations in the glucocorticoid receptor. Clin. Endocrinol. (Oxf.) 2008, 69:673-682.
128. Pereira D.S., Garcia D.M., Narciso F.M., Santos M.L., Dias J.M., Queiroz B.Z., Souza E.R., Nobrega O.T., Pereira L.S. Effects of 174 G/C polymorphism in the promoter region of the interleukin-6 gene on plasma IL-6 levels and muscle strength in elderly women. Braz. J. Med. Biol. Res. 2011, 44:123-129.
129. Perez M., Martin M.A., Canete S., Rubio J.C., Fernandez-Moreira D., San Juan A.F., Gomez-Gallego F., Santiago C., Arenas J., Lucia A. Does the C34T mutation in AMPD1 alter exercise capacity in the elderly?. Int. J. Sports Med. 2006, 27:429-435.
130. Plomin R., DeFries J.C., McClearn G.E., McGuffin P. Behavioral Genetics 2001, Worth, New York. fourth ed.
131. Proctor D.N., Joyner M.J. Skeletal muscle mass and the reduction of VO2max in trained older subjects. J. Appl. Physiol. 1997, 82:1411-1415.
132. Quyyumi A.A., Dakak N., Andrews N.P., Gilligan D.M., Panza J.A., Cannon 3rd R.O. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. Circulation 1995, 92:320-326.
133. Reed T., Fabsitz R.R., Selby J.V., Carmelli D. Genetic influences and grip strength norms in the NHLBI twin study males aged 59-69. Ann. Hum. Biol. 1991, 18:425-432.
134. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 1990, 86:1343-1346.
135. Risch N. Evolving methods in genetic epidemiology. II. Genetic linkage from an epidemiologic perspective. Epidemiol. Rev. 1997, 19:24-32.
136. Rivera A.M., Pels 3rd A.E., Sady S.P., Sady M.A., Cullinane E.M., Thompson P.D. Physiological factors associated with the lower maximal oxygen consumption of master runners. J. Appl. Physiol. 1989, 66:949-954.
137. Robine J.M., Paccaud F. Nonagenarians and centenarians in Switzerland, 1860-2001: a demographic analysis. J. Epidemiol. Commun. Health 2005, 59:31-37.
138. Rockwood K., Nassar B., Mitnitski A. Apolipoprotein E-polymorphism, frailty and mortality in older adults. J. Cell Mol. Med. 2008, 12:2754-2761.
139. Rolland Y., Lauwers-Cances V., Cournot M., Nourhashemi F., Reynish W., Riviere D., Vellas B., Grandjean H. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J. Am. Geriatr. Soc. 2003, 51:1120-1124.
140. Roth S.M., Schrager M.A., Ferrell R.E., Riechman S.E., Metter E.J., Lynch N.A., Lindle R.S., Hurley B.F. CNTF genotype is associated with muscular strength and quality in humans across the adult age span. J. Appl. Physiol. 2001, 90:1205-1210.
141. Roth S.M., Zmuda J.M., Cauley J.A., Shea P.R., Ferrell R.E. Vitamin D receptor genotype is associated with fat-free mass and sarcopenia in elderly men. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59:10-15.
142. Sabina R.L. Myoadenylate deaminase deficiency. A common inherited defect with heterogeneous clinical presentation. Neurol. Clin. 2000, 18:185-194.
143. Sachidanandam R., Weissman D., Schmidt S.C., Kakol J.M., Stein L.D., Marth G., Sherry S., Mullikin J.C., Mortimore B.J., Willey D.L., Hunt S.E., Cole C.G., Coggill P.C., Rice C.M., Ning Z., Rogers J., Bentley D.R., Kwok P.Y., Mardis E.R., Yeh R.T., Schultz B., Cook L., Davenport R., Dante M., Fulton L., Hillier L., Waterston R.H., McPherson J.D., Gilman B., Schaffner S., Van Etten W.J., Reich D., Higgins J., Daly M.J., Blumenstiel B., Baldwin J., Stange-Thomann N., Zody M.C., Linton L., Lander E.S., Altshuler D. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001, 409:928-933.
144. Sadoshima J., Xu Y., Slayter H.S., Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993, 75:977-984.
145. Saini A., Faulkner S., Al-Shanti N., Stewart C. Powerful signals for weak muscles. Age. Res. Rev. 2009, 8:251-267.
146. San Juan A.F., Gomez-Gallego F., Canete S., Santiago C., Perez M., Lucia A. Does complete deficiency of muscle alpha actinin 3 alter functional capacity in elderly women? A preliminary report. Br. J. Sports Med. 2006, 40:e1.
147. Sayer A.A., Syddall H., O'Dell S.D., Chen X.H., Briggs P.J., Briggs R., Day I.N., Cooper C. Polymorphism of the IGF2 gene, birth weight and grip strength in adult men. Age Ageing 2002, 31:468-470.
148. Schrage W.G., Eisenach J.H., Joyner M.J. Ageing reduces nitric-oxide- and prostaglandin-mediated vasodilatation in exercising humans. J. Physiol. 2007, 579:227-236.
149. Schrager M.A., Roth S.M., Ferrell R.E., Metter E.J., Russek-Cohen E., Lynch N.A., Lindle R.S., Hurley B.F. Insulin-like growth factor-2 genotype, fat-free mass, and muscle performance across the adult life span. J. Appl. Physiol. 2004, 97:2176-2183.
150. Seibert M.J., Xue Q.L., Fried L.P., Walston J.D. Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II cohort. J. Am. Geriatr. Soc. 2001, 49:1093-1096.
151. Serrano A.L., Baeza-Raja B., Perdiguero E., Jardi M., Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 2008, 7:33-44.
152. Seto J.T., Chan S., Turner N., Macarthur D.G., Raftery J.M., Berman Y.D., Quinlan K.G., Cooney G.J., Head S., Yang N., North K.N. The effect of alpha-actinin-3 deficiency on muscle aging. Exp. Gerontol. 2011, 46:292-302.
153. Shephard R.J. Maximal oxygen intake and independence in old age. Br. J. Sports Med. 2009, 43:342-346.
154. Siriett V., Platt L., Salerno M.S., Ling N., Kambadur R., Sharma M. Prolonged absence of myostatin reduces sarcopenia. J. Cell Physiol. 2006, 209:866-873.
155. Sleeman M.W., Anderson K.D., Lambert P.D., Yancopoulos G.D., Wiegand S.J. The ciliary neurotrophic factor and its receptor, CNTFR alpha. Pharm. Acta Helv. 2000, 74:265-272.
156. Snejdrlova M., Kalvach Z., Topinkova E., Vrablik M., Prochazkova R., Kvasilova M., Lanska V., Zlatohlavek L., Prusikova M., Ceska R. APOE polymorphism as a potential determinant of functional fitness in the elderly regardless of nutritional status. Neuro. Endocrinol. Lett. 2011, 32:51-54.
157. Sood S., Hanson E.D., Delmonico M.J., Kostek M.C., Hand B.D., Roth S.M., Hurley B.F. Does insulin-like growth factor 1 genotype influence muscle power response to strength training in older men and women?. Eur. J. Appl. Physiol. 2012, 112:743-753.
158. Stathokostas L., Jacob-Johnson S., Petrella R.J., Paterson D.H. Longitudinal changes in aerobic power in older men and women. J. Appl. Physiol. 2004, 97:781-789.
159. Sternberg S.A., Wershof Schwartz A., Karunananthan S., Bergman H., Mark Clarfield A. The identification of frailty: a systematic literature review. J. Am. Geriatr. Soc. 2011, 59:2129-2138.
160. Stratton J.R., Levy W.C., Cerqueira M.D., Schwartz R.S., Abrass I.B. Cardiovascular responses to exercise. Effects of aging and exercise training in healthy men. Circulation 1994, 89:1648-1655.
161. Tiainen K.M., Perola M., Kovanen V.M., Sipila S., Tuononen K.A., Rikalainen K., Kauppinen M.A., Widen E.I., Kaprio J., Rantanen T., Kujala U.M. Genetics of maximal walking speed and skeletal muscle characteristics in older women. Twin Res. Hum. Genet. 2008, 11:321-334.
162. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F., Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet. 1992, 51:197-205.
163. Toth M.J., Gardner A.W., Ades P.A., Poehlman E.T. Contribution of body composition and physical activity to age-related decline in peak VO2 in men and women. J. Appl. Physiol. 1994, 77:647-652.
164. Travison T.G., Shackelton R., Araujo A.B., Morley J.E., Williams R.E., Clark R.V., McKinlay J.B. Frailty, serum androgens, and the CAG repeat polymorphism: results from the Massachusetts Male Aging Study. J. Clin. Endocrinol. Metab. 2010, 95:2746-2754.
165. United-Nations, 2011. World Population Prospects: The 2010 Revision. Dept. of Economic and Social Affairs, United Nations, New York.
166. Van Pottelbergh I., Goemaere S., Nuytinck L., De Paepe A., Kaufman J.M. Association of the type I collagen alpha1 Sp1 polymorphism, bone density and upper limb muscle strength in community-dwelling elderly men. Osteoporos. Int. 2001, 12:895-901.
167. Verdijk L.B., Koopman R., Schaart G., Meijer K., Savelberg H.H., van Loon L.J. Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E151-E157.
168. Vigano A., Trutschnigg B., Kilgour R.D., Hamel N., Hornby L., Lucar E., Foulkes W., Tremblay M.L., Morais J.A. Relationship between angiotensin-converting enzyme gene polymorphism and body composition, functional performance, and blood biomarkers in advanced cancer patients. Clin. Cancer Res. 2009, 15:2442-2447.
169. Visscher P.M., Hill W.G., Wray N.R. Heritability in the genomics era-concepts and misconceptions. Nat. Rev. Genet. 2008, 9:255-266.
170. Volpi E., Nazemi R., Fujita S. Muscle tissue changes with aging. Curr. Opin. Clin. Nutr. Metab. Care 2004, 7:405-410.
171. von Haehling S., Morley J.E., Anker S.D. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J. Cachexia Sarcopenia Muscle 2010, 1:129-133.
172. Wagner K.R., Fleckenstein J.L., Amato A.A., Barohn R.J., Bushby K., Escolar D.M., Flanigan K.M., Pestronk A., Tawil R., Wolfe G.I., Eagle M., Florence J.M., King W.M., Pandya S., Straub V., Juneau P., Meyers K., Csimma C., Araujo T., Allen R., Parsons S.A., Wozney J.M., Lavallie E.R., Mendell J.R. A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann. Neurol. 2008, 63:561-571.
173. Waite L.J. The demographic faces of the elderly. Popul. Dev. Rev. 2004, 30:3-16.
174. Wallace D.C., Ruiz-Pesini E., Mishmar D. mtDNA variation, climatic adaptation, degenerative diseases, and longevity. Cold Spring Harb. Symp. Quant. Biol. 2003, 68:479-486.
175. Walsh S., Liu D., Metter E.J., Ferrucci L., Roth S.M. ACTN3 genotype is associated with muscle phenotypes in women across the adult age span. J. Appl. Physiol. 2008, 105:1486-1491.
176. Walsh S., Metter E.J., Ferrucci L., Roth S.M. Activin-type II receptor B (ACVR2B) and follistatin haplotype associations with muscle mass and strength in humans. J. Appl. Physiol. 2007, 102:2142-2148.
177. Walsh S., Zmuda J.M., Cauley J.A., Shea P.R., Metter E.J., Hurley B.F., Ferrell R.E., Roth S.M. Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men. J. Appl. Physiol. 2005, 98:132-137.
178. Walston J., Arking D.E., Fallin D., Li T., Beamer B., Xue Q., Ferrucci L., Fried L.P., Chakravarti A. IL-6 gene variation is not associated with increased serum levels of IL-6, muscle, weakness, or frailty in older women. Exp. Gerontol. 2005, 40:344-352.
179. Wang X.L., Sim A.S., Wang M.X., Murrell G.A., Trudinger B., Wang J. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 2000, 471:45-50.
180. Wang Y., DeLuca H.F. Is the vitamin d receptor found in muscle?. Endocrinology 2011, 152:354-363.
181. Westerkamp C.M., Gordon S.E. Angiotensin-converting enzyme inhibition attenuates myonuclear addition in overloaded slow-twitch skeletal muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R1223-R1231.
182. Wiebe C.G., Gledhill N., Jamnik V.K., Ferguson S. Exercise cardiac function in young through elderly endurance trained women. Med. Sci. Sports Exerc. 1999, 31:684-691.
183. Williams A.D., Anderson M.J., Selig S., Carey M.F., Febbraio M.A., Hayes A., Toia D., Harrap S.B., Hare D.L. Differential response to resistance training in CHF according to ACE genotype. Int. J. Cardiol. 2011, 149:330-334.
184. Williams A.G., Day S.H., Folland J.P., Gohlke P., Dhamrait S., Montgomery H.E. Circulating angiotensin converting enzyme activity is correlated with muscle strength. Med. Sci. Sports Exerc. 2005, 37:944-948.
185. Windelinckx A., De Mars G., Huygens W., Peeters M.W., Vincent B., Wijmenga C., Lambrechts D., Delecluse C., Roth S.M., Metter E.J., Ferrucci L., Aerssens J., Vlietinck R., Beunen G.P., Thomis M.A. Comprehensive fine mapping of chr12q12-14 and follow-up replication identify activin receptor 1B (ACVR1B) as a muscle strength gene. Eur. J. Hum. Genet.: EJHG 2011, 19:208-215.
186. Yang N., MacArthur D.G., Gulbin J.P., Hahn A.G., Beggs A.H., Easteal S., North K. ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet. 2003, 73:627-631.
187. Yao L., Delmonico M.J., Roth S.M., Hand B.D., Johns J., Conway J., Douglass L., Hurley B.F. Adrenergic receptor genotype influence on midthigh intermuscular fat response to strength training in middle-aged and older adults. J. Gerontol. A Biol. Sci. Med. Sci. 2007, 62:658-663.
188. Yoshihara A., Tobina T., Yamaga T., Ayabe M., Yoshitake Y., Kimura Y., Shimada M., Nishimuta M., Nakagawa N., Ohashi M., Hanada N., Tanaka H., Kiyonaga A., Miyazaki H. Physical function is weakly associated with angiotensin-converting enzyme gene I/D polymorphism in elderly Japanese subjects. Gerontology 2009, 55:387-392.
189. Yoshimura M., Yasue H., Nakayama M., Shimasaki Y., Sumida H., Sugiyama S., Kugiyama K., Ogawa H., Ogawa Y., Saito Y., Miyamoto Y., Nakao K. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum. Genet. 1998, 103:65-69.
190. Zempo H., Tanabe K., Murakami H., Iemitsu M., Maeda S., Kuno S. ACTN3 polymorphism affects thigh muscle area. Int. J. Sports Med. 2010, 31:138-142.